Interferon gamma release assays for monitoring the response to treatment for tuberculosis: A systematic review

While quantitative IGRA responses generally fall during treatment for TB, the large degree of variation in results between participants in each study means that IGRAs are unlikely to be useful for monitoring anti-tuberculous treatment in clinical practice for any individual patient.